Objectives: To compare the levels of serum pepsinogen (PG) in patients with gastric cancer (GC), patients with atrophic gastritis (AG), and healthy donors. Also, we explored the clinical value of PG detection for the diagnosis and treatment of GC.
Methods: The PG level in peripheral blood from patients and heathy donors was determined using an Abbott automatic chemiluminescence instrument.